InvestorsHub Logo
icon url

Whalatane

03/04/23 1:01 PM

#404837 RE: Laurent Maldague #404836

Re

IPE clearly has no equal.


So can you show me an independent double blinded Outcome trial run in US CAD patients without a mineral oil placebo ....to support that statement ?
I'm not asking for a whole re run of R-IT ...but maybe 2 yrs of MITIGATE data to match the event line separation at 2 yrs in R-IT
2 yrs of data ....what's that... Sept 2023 ?
AMRN funded this to Feb 28th 2023 ...why not to Sept 2023 ?

MITIGATE was fully enrolled in Sept 2021...and they are tracking CV endpoints .
Why the radio silence on MITIGATE ...which apparently was completed on Feb 28th .
No notice like ...Trial is completed ...Data is locked and results will be released in about _______

How about Real World Data . Kaiser must have enough by now on their secondary prevention CAD patients ?

Now before U all get in a tizzy about this post ....I'm one of the chief beneficiary's of the R-IT numbers the Capt just posted if independently confirmed .
I'm still taking my 4 gms of Vascepa daily and would continue to do so even if the RR was half of what is currently claimed .

Kiwi